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Abstract
Overuse of antibiotics pose serious consequences for patient’s well-being, including the
risk for antibiotic resistance and adverse effects from inadequate and timely treatment.
The emergence and frequency of multi-drug resistant bacteria are alarming global public
health care experts, as these strains are resisting effective management of life-threatening
infections. The gap in practice was that a retail pharmacy clinic did not have a practice
guideline for the implementation of a wait-and-see prescription program as part of an
antimicrobial stewardship program. The purpose of this project was to coordinate an
interprofessional team to develop guidelines for this primary care setting. The practicefocused question addressed whether a multiprofessional team could develop tailored
guidelines that would result in the adoption as a standard of care in this retail clinic. This
project emphasized the implementation of the theory of planned behavior in prescribing
medications, improving attitudes toward a particular behavior, altering the norm, and
controlling perceived behavior, resulting in a better health outcome. A 3-member team
consisting of a nurse practitioner, primary care physician, and pharmacist evaluated the
evidence-based practice guideline using the Appraisal of Guidelines for Research &
Evaluation II (AGREE II) tool rated on a 7-point Likert scale from strongly agree to
strongly disagree. Findings showed 100% agreement as agree or strongly agree on 21
out of 23 items with partially agree on 2 items. No disagreement was noted. The
guideline was submitted to project site leadership for adoption as a clinical standard. This
guideline may be used in other retail clinics across the company and United States to
reduce the overuse of antibiotics and the risk of patients developing antibiotic resistance.
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Section 1: Nature of the Project
The World Health Organization (WHO, 2019) ranked the problem of antibiotic
resistance as a high priority. In response to this emerging public health issue, the
Infectious Disease Society of America and the Society for Healthcare Epidemiology of
America (as cited in Kimura et al., 2018) have established guidelines for an antibiotic
stewardship program. The clinical gap in practice was the lack of an antibiotic
stewardship program with clinical guidelines for nurse practitioners (NPs) to implement a
wait-and-see antibiotic prescription program in a retail pharmacy clinical setting. Primary
care providers (PCPs) and NPs need a better understanding of the concepts and tools to
address patients about the wait-and-see approach to antibiotic use. The project included a
multidisciplinary team to establish clinical guidelines specific to implementing the waitand-see approach and the antibiotic stewardship program in the retail clinic.
Implementing the guidelines may reduce antibiotic abuse and antimicrobial resistance in
the patient population.
Problem Statement
Health care clinics associated with retail pharmacies are a popular source of
primary and secondary care (Mehrotra et al., 2009). The most common illnesses seen are
urinary tract infections, otitis media, and pharyngitis, all conditions commonly treated
with antibiotics (Mehrotra et al., 2009). Unnecessary antibiotic prescriptions increase the
cost of the health care industry. Overuse of antibiotics promotes a false belief that
antibiotics are always the answer to illness when many diseases are viral and are not
appropriate for antibiotic prescriptions (Borde et al., 2015). Overuse of antibiotics poses
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serious consequences for patients’ well-being, including the risk for antibiotic resistance
and adverse effects from inadequate and timely treatment. The emergence and frequency
of multi-drug-resistant bacteria are alarming global public health care experts, as these
strains are resisting effective management of life-threatening infections (Borde et al.,
2015). The WHO (2019) has ranked the problem of antibiotic resistance as a high priority
on its agenda.
In response to this emerging public health crisis of antibiotic resistance, the
Infectious Disease Society of America and the Society for Healthcare Epidemiology of
America (as cited in Kimura et al., 2018) have established guidelines for an antibiotic
stewardship program. Several strategies have been established to minimize the
unnecessary use of antibiotics (Abad et al., 2019). One approach is the wait-and-see or
delayed antibiotic prescription, in which a prescription is given for the patient only to
take if the condition worsens or does not improve a couple of days after the clinician
visit. Sargent, McCullough, Del Mar, and Lowe (2017) found that delayed prescription is
one strategy that decreases antibiotic use. In their study, 93% of patients who received an
immediate script filled the prescription, compared to nearly 32% who were given a
delayed prescription. For patients reporting with an acute sore throat and otitis media, the
immediate antibiotic script offers faster relief than a wait-and-see script, but there is an
increased incidence of side effects such as nausea, vomiting, and diarrhea (Sargent et al.,
2017). The success and cost-effectiveness of antibiotic stewardship programs have been
analyzed in systemic reviews in hospital settings, including patients in critical care units
(Lee et al., 2018).
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Although the wait-and-see program has been adopted by many private PCPs, the
project site retail clinic, which has approximately 7,400 patient visits annually, did not
have clinical guidelines enabling its adoption by providers in this setting. This suggests
that a population may not be receiving the optional antibiotic stewardship practice. Nurse
practitioners have the professional responsibility to provide the best evidence-based care
for their patients. Adopting existing guidelines in this expanding sector of primary care
has the potential to spread across the estimated 2,800 clinics in the United States (Rand
Corporation, 2018). With large retail stores such as Walmart and Target opening clinics
in addition to the expansion by retail pharmacies such as CVS, ensuring that nurse
practitioners have the latest evidence-based practice guidelines is important.
Purpose
The gap in practice was no antibiotic stewardship program in the clinical setting
with clinical guidelines for NPs to implement a wait-and-see antibiotic prescription
program. PCPs and NPs need a better understanding of the concepts and tools to address
patients and parents of children about the wait-and-see approach to antibiotic use.
Managing patient expectations is challenging, especially in retail clinics that have no
PCPs, limited economic means, and cultural expectations regarding the use of antibiotics.
The purpose of the project was to develop focused clinical guidelines specific to
implementing the wait-and-see approach and the antibiotic stewardship program in this
retail clinic.
The practice-focused question was the following: Will the development of clinical
practice guidelines on the implementation of the wait-and-see prescription program as
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part of an antimicrobial stewardship program result in the adoption of this program as a
standard of care in this retail clinic? The adoption of this program has the potential to
address the gap in practice and promote NP awareness of the need for antibiotic
stewardship. The wait-and-see approach is the first step to a broader antibiotic
stewardship program as NPs and PCPs bring change in practice during the episodes of
illness. The project materials included educational resources to use for patient education.
The goal is to reduce the overuse of antibiotics and the risk of patients developing
antibiotic resistance.
Sources of Evidence
Journal articles from CINAHL, Medline, Cochrane Database of Systematic
Reviews, and the Walden Search Center were used as sources of evidence in the project.
The search words included antibiotic stewardship, wait-and-see antibiotics, antibiotic
resistance, and cultural norms for medication use. The search was limited to peerreviewed, full-text, English-only articles published in the last 5 years and included the
clinical practice guidelines suggested by professional associations and the Centers for
Disease Control and Prevention (CDC).
The development of the wait-and-see clinical practice guidelines followed the
Walden University (2019b) Manual for Clinical Practice Guideline Development.
Information from the literature and guidelines from the professional associations were
reviewed and evaluated using the Grading of Recommendation Assessment Development
and Evaluation (GRADE) criteria (see Appendix B). The GRADE working group
established a tool called the GRADE system to grade the quality of evidence in research
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and examine the strength of recommendation of the intervention suggested in the article
(Phi et al., 2012). The GRADE system includes four factors to establish the quality of
evidence: study design, consistency, direction, and study quality. I used the four factors
to evaluate the evidence and make recommendations regarding the intensity of
intervention. The GRADE is used to establishes a qualitative assessment of evidencebased practice and does not include quantitative data. Phi et al. (2012) expanded the
GRADE by quantifying the strength of recommendation and quality of evidence of the
initial GRADE. With the expansion of the GRADE to the Ex-GRADE, researchers have
a new tool to close the gap between evidence-based practice and clinical practice. This
tool emphasizes the cost and benefit concerns that many clinicians and clients need
clarification about before starting an intervention.
The project team met over several weeks to discuss the evidence and to develop
the clinical practice guidelines. I led the discussions and wrote the drafts until the group
reached consensus. At that point, another panel consisting of an NP, physician, and
pharmacist from another setting reviewed the guidelines using the Appraisal of
Guidelines for Research & Evaluation II (AGREE II, 2013). The purpose of AGREE II
(2013) is to give a framework to assess the quality of guidelines, offer a methodological
strategy for the establishment of guidelines, and offer information on what needs to be
reported in guidelines. AGREE II replaces the original tool as a tool of choice and can be
used with the overall results of enhancing health care. AGREE II includes 23 individual
tools organized into six domains. The AGREE II instrument is scored per the instructions
provided by the Agree Trust. The guideline is revised based on recommendations, and a
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final report is written for dissemination to key stakeholders for approval to implement the
program.
Significance
Those who may benefit from this project are adult patients and parents of
pediatric and adolescent patients who have no primary care doctors, limited economic
means, and cultural expectations regarding the use of antibiotics. The project could have
an impact on NPs by giving them evidence-based practice guidelines to address antibiotic
stewardship. The positive social changes anticipated are more appropriate antibiotic use,
cost-effective practice, decreased risk of antibiotic-resistant strains of infection, change in
NP practice, and a culture change in the community.
The clinic leadership at the project site was supportive of this project. The team
was eager to learn more and to be one of the first to adopt this type of program in the
retail pharmacy sector in this state. The mission of Walden University is to enhance,
support, and facilitate research and projects that bring positive social change. This project
supported the mission of Walden to promote positive change. I enlisted an NP,
pharmacist, and consulting physician to promote evidence-based practice in this setting.
The project may lead to this retail clinic implementing a wait-and-see antibiotic
stewardship program, which may benefit NPs, patients, and the community. This
implementation would be consistent with the best practice suggested for primary care
nurse practitioners to promote infection prevention (American Association of Nurse
Practitioners, 2019).
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Summary
Overuse of antibiotics results in serious consequences for patients’ health,
including the risk for antimicrobial resistance and adverse effects from inadequate and
timely treatment. Several strategies have been developed to minimize the unnecessary use
of antibiotics (Abad et al., 2019). One approach is delayed antibiotic prescription or waitand-see, in which a prescription is given for the patient only to take if the condition
worsens or does not improve a few days after the clinician visit. The purpose of the
project was to develop focused clinical guidelines specific to implementing the wait-andsee approach and the antibiotic stewardship program in this retail clinic. Once
implemented and evaluated, this project may serve as a model for other retail clinics.
Those who may benefit from this project are adult patients who have no primary care
doctors, limited economic means, and cultural expectations regarding the use of
antibiotics. The positive social changes anticipated are more appropriate antibiotic use,
cost-effective practice, decreased risk of antibiotic-resistant strains of infection, change in
practice, and a culture change in the community.
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Section 2: Background and Context
Unwarranted antibiotic prescriptions increase expenses in health care. Misuse of
antibiotics offers a wrong belief that antibiotics are the only answer to illness when most
viral infections do not require an antibiotic prescription (Borde et al., 2015). Misuse of
antibiotics has serious repercussions for patient health, antibiotic resistance, and side
effects. The increasing number of antibiotic-resistant disease strains is a threat to global
health care (Borde et al., 2015). Many strategies have been developed to overcome the
unwarranted use of antibiotics (Abad et al., 2019). The use of wait-and-see or delayed
antibiotic prescription is a strategy that minimizes antibiotic use (Sargent et al., 2017).
The practice-focused question was the following: Will the development of clinical
practice guidelines on the implementation of the wait-and-see prescription program as
part of an antimicrobial stewardship program result in the adoption of this program as a
standard of care in this retail clinic? The gap in practice was the lack of antibiotic
stewardship protocol at the project clinic with clinical guidelines for NPs to implement a
wait-and-see antibiotic program. NPs and PCPs require more understanding of the
concepts and approaches to addressing patients and parents of children on the wait-andsee concept to antibiotic use. Meeting patient expectations requires strategies to
overcome challenges commonly seen in retail clinics with patients who have limited
resources, have cultural expectations on antibiotic use, and do not have PCPs. The
purpose of the project was to establish focused guidelines geared toward applying into
practice the stewardship antibiotic and wait-and-see program in the retail clinic.
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Concept, Models, and Theories
The health promotion model was established by Pender to be a “complementary
counterpart to models of health protection” (Nursing Theory, 2016, para. X). The health
promotion model defines health as a positive dynamic state rather than the absence of
disease. Health promotion is directed at increasing a patient’s level of well-being. The
health promotion model describes the multidimensional nature of the person as they
interact within their environment to pursue health. The health promotion model includes
four assumptions: (a) the individual seeks to actively regulate their own behavior; (b)
individuals, in all their biopsychosocial complexity, interact with the environment,
progressively transforming the environment as well as being transformed over time; (3)
health professionals such as nurses constitute a part of the interpersonal environment that
exerts influence on people through their life span; and (4) self-initiated reconfiguration of
the person-environment interactive patterns is essential to changing behavior. Pender’s
model focuses on three areas: individual characteristics and experiences, behaviorspecific cognitions and affect, and behavioral outcomes. The theory notes that each
person has unique personal characteristics and experiences that affect subsequent actions
(Nursing Theory, 2016).
The set of variables for behavior-specific knowledge and effect have important
motivational significance. The first part of the wait-and-see model is to assess the
patient’s belief about the disease and the use of antibiotics. The variables can be modified
through nursing actions. Health-promoting behavior is the desired behavioral outcome,
which makes it the end point in the health promotion model. These behaviors should
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result in improved health, enhanced functional ability, and better quality of life at all
stages of development. The final behavioral demand is also influenced by the immediate
competing demand and preferences, which can derail intended actions for promoting
health.
The literature supports the utilization of psychological theories to discover
facilitators and challenges to changing behavior in clinical settings (Sargent et al., 2017).
The theory of planned behavior identified an eight-step guide to developing intervention
using theoretical perspective. The first four measures assist researchers in clarifying the
targeted behavior. The first measure is identifying and describing the problem from
behavioral perspective. The second measure is selecting targeted behavior. The third
measure is specifying behavior such as the when, the what, the where, the whom, and the
how often. The fourth measure is identifying what must change to accomplish behavior
by examining interview data with the theoretical framework. The theory of planned
behavior has 14 theoretical domains showing anticipated theory-based motivators and
challenges to change in behavior (Sargent et al., 2017).
The Watson (2012) theory of human caring focuses on improvement in nursing
self-care behaviors and can benefit patients in several ways. Between 1975 and 1979,
Watson (as cited in Zaccagnini & White, 2017) acquainted human caring theory to clarify
her supposition that nursing practice, knowledge, and values center on the patient’s
personal encounters and healing processes. The theory’s significant concepts include the
caring moment, caring healing modalities, and the transpersonal caring relationship
(Zaccagnini & White, 2017). Watson’s 10 carative factors energize or advocate the
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following: sensitivity to oneself as well as other people, helping-trusting relationship,
humanistic-altruistic system, expression of feelings, faith-hope, requires satisfaction,
existential-phenomenology-spiritual forces, transpersonal educating learning, creative
problem-solving, and steady condition (Zaccagnini & White, 2017).
Watson advised loving-kindness practice. For example, as patients’ demand for
antibiotic prescriptions increases, they need additional time and require more provider
attention to explain the wait-and-see antibiotic program. Tending to these practices
should enhance health promotion and disease prevention. Patients living in low
socioeconomic conditions, those who are uninsured, or those who do not have PCP may
have spiritual and psychological needs or cultural beliefs that need to be addressed
to ease health promotion and disease prevention. Watson pointed out the need to create
helping-trusting relationships with those who demand antibiotics and encouraged the
expression of feelings. Watson’s theory suggests that nurses take part in the process
of teaching and learning from the other point of view. Quality care for antibiotic
stewardship requires a nurse practice environment in which the processes and use of
clinic resources and services are based on individual patient care needs.
Relevance to Nursing Practice
There is an increasing need for understanding approaches for establishing
intervention to change practice and the health care profession’s behavior. Previous
studies have shown the link between systemic reviews and primary research. The
outcome of the studies was to establish pilot intervention and to combine previous studies
to develop intervention recommendations supported by theory and research (Lucas et al.,
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2017). The lack of guidelines in the clinical practice may contribute to poor quality of
care caused by the unnecessary prescription of antibiotics intending to treat or prevent
infections. Inappropriate dosing, selection, and duration of antibiotics increase antibiotic
resistance. Kimura et al. (2018) argued that diagnosis and prescription are not adequately
administered because of an improper sample collection technique for bacterial or fungal
cultures. The comprehensive antibiotic stewardship program includes strategies that
reduce the development of resistant microorganisms and improves the quality of care
(Kimura et al., 2018).
Many strategies have been developed to decrease the unnecessary use of
antibiotics (Abad et al., 2019). An interesting approach introduced is the wait-and-see or
delayed antibiotic prescription, in which a prescription is offered for the patient to take
only if the condition does not improve after the provider visit. The adoption of this
program may address the gap in current practice and promote NP understanding of the
need for antibiotic stewardship. The approach encourages providers to engage in
implementing the wait-and-see antibiotic program and change the scope of practice
(Borde et al., 2015). Outcomes from the current project may include guidelines being
adopted, stewardship being enhanced, and change being implemented in the standard of
care.
Local Background and Context
According to the CDC (2019), 20% to 50% of all prescribed antibiotics for acute
care hospitals are inappropriate or unnecessary. In the United States, nearly 13% of walkin visits, or about 154 million visits every year, receive antibiotic prescription (PEW,
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2018). Nearly 30% of these prescriptions, or 47 million written prescriptions, are deemed
unnecessary. To help solve the challenges of antibiotic overprescription, CVS Health
partnered with the CDC to support the efforts of antibiotic stewardship (CDC, 2019). The
U.S. government’s antibiotic resistance challenge is an ongoing effort to motivate the
fight against antibiotic resistance. The antibiotic resistance challenge is an attempt in
which government organizations, nongovernment organizations, and private companies
throughout the world try to come up with official commitment that will support and
advance efforts against antimicrobial resistance. The current project took place in a retail
clinic after the approval of the Walden’s Institutional Review Board (# 06-05-200747556).
Role of the DNP Student
I used the clinical practice guidelines suggested by professional associations and
the CDC. The establishment of the wait-and-see clinical practice guidelines adhered to
the Walden University (2019b) Manual for Clinical Practice Guideline Development. I
analyzed articles using the GRADE criteria. The GRADE working group developed a
tool called the GRADE system; its purpose is grading the quality of evidence in research
and evaluating the strength of recommendation of the intervention given in the article
(Phi et al., 2012). Phi et al. (2012) expanded the GRADE by analyzing the strength of
recommendation and quality of evidence of the initial GRADE. By advancing the
GRADE to Ex-GRADE, Phi et al. developed a new tool that can close gaps between
evidence-based practice and clinical practice. I used this tool to address the cost-benefit
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concerns that many clinicians and clients need to understand before starting an
intervention, which helps to direct individuals through the decision-making process.
The project team met over several weeks to discuss the evidence and to establish
the clinical practice guidelines. I led the team in the discussion and writing of drafts until
the group reached its conclusion. After this, another panel consisting of a physician, NP,
and pharmacist from another setting reviewed the guidelines using the AGREE II (2013).
With the use of the AGREE II instrument, the expert panel examined the guidelines to
validate the content. The purpose of AGREE II is to provide a framework to assess the
quality of guidelines, offer a methodological strategy for the establishment of guidelines,
and offer information on what needs to be reported in guidelines. I was motivated to
implement the project on antibiotic stewardship because U.S. antibiotic resistance
increased to about 23,000 plus deaths every year and about 2 million illnesses (CDC,
2017).
Summary
Misuse of antibiotics has severe consequences for patient health, antibiotic
resistance, and other side effects. Many strategies have been developed to overcome the
inappropriate use of antibiotics (Abad et al., 2019). The wait-and-see antibiotic
prescription is a strategy that minimizes antibiotic use (Sargent et al., 2017). The
successful outcome and cost-effective approaches of antibiotic stewardship programs
have been studied in hospitals, including retail clinics (Lee et al., 2018). Medical
facilities require proper strategies that improve the growth of health care in individuals
and expand the extent of medical care on diagnosis and prognosis. The three models,
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including Pender’s health promotion model, the theory of planned behavior, and
Watson’s theory of human caring, were used to advance the study of quality of care on
antibiotic stewardship program (see Kamekis et al., 2018). The gap in practice was the
lack of antibiotic stewardship protocol in the project site clinic, including clinical
guidelines for NPs to apply a wait-and-see antibiotic program. NPs and PCPs require
more understanding of the concepts and approaches to addressing patients and parents of
children on the wait-and-see approach to antibiotic use. The project may lead to more
cost-effective practice, more appropriate antibiotic use, decreased antibiotic resistance,
and a changing culture in the community.
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Section 3: Collection and Analysis of Evidence
Unnecessary use of prescription antibiotics increases the cost of health care.
Uncontrolled use of antibiotics promotes a false belief that taking antibiotics is the only
answer to treat an illness, when most of these infections do not need an antibiotic
prescription (Borde et al., 2015). Overuse of antibiotics has serious ramifications for
patients’ well-being, antibiotic resistance, and adverse effects. The prevalence of
antibiotic resistance poses an imminent danger to global health care (Borde et al., 2015).
Many strategies have been established to address the excessive use of antibiotics (Abad et
al., 2019). The use of delayed antibiotic prescriptions or wait-and-see prescriptions is an
action plan that decreases antibiotic use (Sergent et al., 2017).
The practice-focused question was the following: Will the development of clinical
practice guidelines on the implementation of the wait-and-see prescription program as
part of an antimicrobial stewardship program result in the adoption of this program as a
standard of care in this retail clinic? The gap in practice was the need for antibiotic
guidelines and a protocol for NPs to implement a wait-and-see antibiotic program. NPs
and PCPs need more knowledge on the concepts and strategies to educate patients and
parents of children on the antibiotic stewardship programs. Fulfilling patient’s needs
requires an action plan to overcome challenges frequently seen in walk-in clinics for
those living in low socioeconomic conditions, those who do not have enough resources,
those who do not have PCPs, and those who have set cultural beliefs on antibiotic use.
The purpose of the project was to develop focused guidelines to implement into practice a
wait-and-see and antibiotic program in walk-in clinics.
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Sources of Evidence
The sources of evidence for the antibiotic stewardship project included journal
articles from Medline, CINAHL, the Walden Search Center, and the Cochrane Database
of Systematic Reviews. The search words including wait-and-see antibiotics, antibiotic
stewardship, cultural norms for medication use, and antibiotic resistance. The search
included only full-text, peer-reviewed, and English-only articles published in the last 5
years. I used the clinical practice guidelines advised by CDC and professional
organizations.
I collected information from the guidelines and literature and from professional
organizations. The development of the wait-and-see clinical practice guidelines adhered
to the Walden University (2019b) Manual for Clinical Practice Guideline Development. I
analyzed and evaluated the articles using the GRADE criteria. The GRADE working
group developed a tool called the GRADE system, which is used to grade the quality of
evidence in research and examine the strength of recommendation of the intervention
suggested in the article (Phi et al., 2012). The GRADE includes four factors to establish
the quality of evidence: study design, consistency, direction, and study quality. The
recommendation of the intensity of intervention is developed by combining the four
factors and evaluating the grade of evidence. The GRADE establishes a qualitative
assessment of evidence-based practice and does not produce quantitative data. Phil et al.
(2012) expanded the GRADE by quantifying the strength of recommendation and quality
of evidence of the initial GRADE. By expanding the GRADE to Ex-GRADE, Phil et al.
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established a new tool that can be used to close gaps between evidence-based practice
and clinical practice.
The project team included an NP, physician, and pharmacist who were chosen to
review the guidelines using the AGREE II (2013). Using the AGREE II instrument, the
expert panel reviewed the guidelines to validate the content. I chose these health care
professionals based on their skills, abilities, integrated knowledge, and anticipation for
nursing practice (see Melnyk & Fineout-Overholt, 2019). Competencies are necessary to
deliver high-quality care, especially in an era when antibiotic stewardship accompanied
by antibiotic resistance is increasing by about 23,000 plus deaths each year in the United
States (CDC, 2017). The use of competencies may improve variability in health care
systems and enhance the education of clinicians by introducing a clinical guideline for
practice change.
The retail clinic leadership was supportive of this program as part of the overall
total quality improvement mission of the organization. Team members and the review
team participated voluntarily and were informed of the purpose, scope, and outcome of
the project. Their individual identities were protected. All participants consented to
participate using the consent for anonymous questionnaires in the DNP Staff Education
Manual. This project was approved by the Walden Institutional Review Board.
Analysis and Synthesis
I led the discussions and wrote the drafts until the group reached consensus. The
team met over 3 weeks to discuss the evidence and to develop the clinical practice
guidelines. At that point, another panel consisting of an NP, pharmacist, and physician
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from another setting were asked to evaluate the guidelines using the AGREE II (2013).
Using the AGREE II instrument, the expert panel analyzed the guidelines to validate the
content. The purpose of AGREE II is to provide a framework to examine the quality of
guidelines, offer a methodological strategy for the establishment of guidelines, and offer
information on what needs to be reported in guidelines. AGREE II replaced the original
tool as a tool of choice and can be used with the overall objective of improving health
care. AGREE II includes 23 individual tools organized into six domains (AGREE II,
2013). The AGREE II instrument is scored per the instructions provided by the Agree
Trust. I revised the guidelines based on the expert panel recommendations, presented a
final report with the guidelines to the team for their endorsement, and provided the final
report to key stakeholders for approval to implement the program.
Summary
Overuse of antibiotics has serious ramifications for patients’ health, including the
risk for adverse effects and antibiotic resistance from inadequate and timely treatment.
The prevalence of multi-drug-resistant bacteria is frightening global public health care
experts, as these strains are resisting the successful management of life-threatening
infections (Borde et al., 2015). The WHO (2019) has categorized the problem of
antibiotic resistance as a high priority on its agenda. In this section, I explored many
sources of evidence to address the practice problem.
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Section 4: Findings and Recommendations
Antibiotics are a class of medications that are often used to treat bacterial
infections. Their overuse poses serious consequences for patients’ well-being, including
the risk of antibiotic resistance and adverse effects from excessive use (Borde et al.,
2015). In this project, I sought to develop a guideline that would enhance advanced
practice nurses’ knowledge, attitude, and perceptions about the use of antibiotics and
decrease the development of antibiotic resistance.
Purpose
The purpose of this project was to develop clinical practice guidelines with a
multidisciplinary team to implement the wait-and-see antibiotic stewardship program
(ASP) in a retail clinic. PCPs and NPs need a better understanding of the concepts and
tools to address patients about the wait-and-see approach to antibiotic use.
Sources of Evidence
The development of the wait-and-see clinical practice guidelines followed the
Walden University (2019b) Manual for Clinical Practice Guideline Development. The
information was gathered from the literature and from guidelines from the professional
associations. The following sources of evidence were searched: journal articles from
Medline, CINAHL, and the Cochrane Database of Systematic Reviews. The following
keywords were used: antibiotic stewardship, wait-and-see antibiotics, cultural norms for
medication use, and antibiotic resistance. The search included only full-text, peerreviewed, and English-only articles that were published in the last 5 years. The clinical
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practice guidelines published by the CDC and professional organizations were used to
gather information.
The articles were reviewed using the GRADE approach. A working group
established this tool to grade the quality of evidence in research and to examine the
strength of recommendations (Phi et al., 2012). In 2012, GRADE was expanded to ExGRADE and the focus was on quantifying the strength of recommendation and quality of
evidence of the initial GRADE (see Appendix B). This expansion of the GRADE (ExGRADE) resulted in the creation of a new tool that can produce data and possibly bridge
the gap between evidence-based research and clinical practice. This new tool was used to
emphasize the cost and benefit that many clinicians and clients need to understand before
starting an intervention. Ex-GRADE helps guide individuals through the decision-making
process.
The first draft of the guideline was presented to the review team via Google docs.
Their comments were reviewed and incorporated into the proposed final guideline (see
Appendix A). This final guideline was circulated with an accompanying AGREE II
assessment. The assessment results are presented in Table 1. In summary, 12 areas were
rated strongly agree by 66% and agree by 33%. Nine areas were rated strongly agree by
33% and agree by 66%. Only two of the 23 items were rated partially agree, agree, and
strongly agree by 33%. Those two items were systematic methods used to search for
evidence and the criteria for selecting the evidence. A copy of the final guidelines and the
results of the AGREE II tool were forwarded to clinical leadership for final approval
before implementation.
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Table 1
AGREE II Instrument Rating of Clinical Practice Guidelines
Domain

SA

A

1. The overall objective of the guideline is specifically
described
2. The health question covered by the guideline is specifically
described
3. The population to whom the guideline is meant to apply is
specifically described
4. The guideline development group includes individuals from
all the relevant professional groups
5. The views and preferences of the target population have
been sought
6. The target uses of the guidelines are clearly defined
7. Systematic methods were used to search for evidence
8. The criteria for selecting the evidence are clearly described
9. The strengths and limitations of the body of evidence are
clearly described
10. The methods for formulating the recommendations are
clearly described
11. The health benefits, side effects and risks have been
considered in formulating the recommendations
12. There is an explicit link between the recommendations
and the supporting evidence
13. The guideline has been externally reviewed by experts
prior to its publication
14. A procedure for updating the guideline is provided
15. The recommendations are specific and unambiguous
16. The different options for the management of the condition
or health issue are clearly presented
17. Key recommendations are easily identifiable
18. The guidelines provide advice and/ or tools on how the
recommendations can be put into practice
19. The guidelines describe facilitators and barriers to its
application
20. The potential resource implications of applying the
recommendations has been considered
21. The guidelines present monitoring and/ or auditing criteria
22. The views of the funding body have not influenced the
content of the guideline
23. Competing interests of guideline development group
members have been recorded and addressed

1

2

1

2

2

1

2

1

1

2

1
1
1
1

2
1
1
2

1

2

2

1

2

1

2

1

2
2
1

1
1
2

2
2

1
1

1

2

1

2

2
2

1
1

2

1

PA

N

PD

D

SD

1
1

Note. Rating scale: (1) strongly agree, (2) agree, (3) partially agree, (4) neutral, (5) partially disagree, (6)
disagree, (7) strongly disagree.
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Summary of Guidelines
The expert panel was compliant with the GRADE in establishing other guidelines,
which incorporated systemic weighing of quality of evidence and strength of
recommendation using the GRADE system. The summary of guidelines includes the use
of ASP, educating NPs, audit of antibiotic use and feedback reports about ASP, using
ASP guidelines that are on ASP based on epidemiology, using published data, reviewing
data, and computerized surveillance that will discourage mixing antibiotics in a patient.
The guidelines may encourage using pharmacokinetics monitoring, oral antibiotics,
shorter-duration treatment, rapid viral testing, monitoring costs, and patients’ cultural
consideration and sensitivity in prescribing antibiotics.
Recommendations
•

The use of the wait-and-see approach or delayed antibiotic prescription, in
which a prescription is given to a patient to take only if the condition worsens
or if it does not improve few days after the clinician visit.

•

ASP education sessions to NPs using lectures or posters to teach providers and
clients about the beneficial aspects of ASP intervention for reducing
inappropriate antibiotic use.

•

Use of ASP guidelines and algorithms, based on epidemiology, by retail
clinics to standardize prescription practices for common infections to improve
antibiotic use and patient outcomes (see Appendix A).

•

Chart audits and the audit tool in the ASP program (see Appendix C).
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•

Implementation of monthly quality improvement summary form (see
Appendix D).

•

Strategies including the use of published data on prescriber-led, routine
review of antibiotic regimens to enhance antibiotic prescribing and wait-andsee prescribing.

•

Use of pharmacokinetic monitoring and dose adjustment for aminoglycosides
antibiotics to reduce side effects, reduce cost, and improve outcome.

•

Use of oral antibiotics to decrease the cost.

•

Use of a shorter duration of therapy or specifying the duration of therapy at
the time of antibiotic ordering.

•

Use of microbiology laboratory or susceptible culture test results in
prescribing antibiotics in common clinical conditions.

•

Rapid viral testing. If the test results are viral, supportive therapy follows; if
the test results reveal a bacterial infection, 24 hours of wait-and-see antibiotic
prescription is suggested.

•

Measuring antibiotic costs depending on prescriptions or administrations
rather than on purchasing data.

•

Use of rapid diagnostic testing with culture and sensitivity testing for
antibiotic prescribing.

•

Implementation of a computerized surveillance system to synthesize data from
electronic medical records and other data sources to improve the work of ASP
by recognizing an opportunity for intervention.
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Roles and Responsibilities for Implementation
The next step is implementation of the wait-and-see approach at the project site
clinic. The physician will supervise training, monitor intervention, and provide training,
surveillance systems, algorithms, and monthly logs. The physician will ensure that the
collected data are accurate. The NP will offer education sessions, audits, and feedback
reports; collect algorithms data; collect surveillance system data; answer questions;
collect the monthly logs data; and work with other providers to ensure that the data
collected are accurate, complete, and identified prior to receiving them. The NP will
ensure follow up when the laboratory reports are needed, delays are encountered, culture
and sensitivity orders are needed, and rapid viral testing reports are available and will
assist the person who is designated to identify and collect the data for the project. The
pharmacist will monitor the mixing of antibiotics, pharmacokinetic and dosageadjustment monitoring, shorter antibiotics use, and use of oral antibiotics to decrease
cost.
Strengths and Limitation of the Project
The first strength is that the project team was fully committed to the project and
worked together to develop the ASP. Lessons learned from implementing the guidelines
into practice may inform changes to the guidelines. The limitation is that the guidelines
were developed for one retail clinic. The guidelines will need to be implemented and
evaluated to determine their efficacy.
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Section 5: Dissemination Plan
The ASP guidelines were presented to the stakeholders and management team as
a written report. The report included the use, education, audit, and feedback reports. The
ASP guidelines were based on epidemiology, published data, review, and computerized
surveillance, and discouraged mixing antibiotics. In addition, findings including the
monthly reports, quarterly logs, audits completed, compliance with ASP guidelines,
policies and procedures, and areas requiring improvement were added to the report.
Furthermore, the report included recommendations for future practice and a request for a
24-month evaluation following a 2-year period for publication. The audience and settings
that would meet the criteria for the dissemination of the project are CVS retail clinics,
Walmart clinics, Walgreens clinics, and Target retail clinics. The forum would be divided
into the NP monthly briefing sessions, ongoing analysis assessment, and roundtable
meeting with other retail clinics to discuss global influence and opportunities.
Analysis of Self
The main thing I have learned about myself while working on this project was
that I enjoyed the concept of quality improvement and evidence-based clinical practice.
During my DNP program, I have played the role of an intellectual by researching current
evidence-based practice resources and implementing them to ASP at the retail clinic. My
role included project leader and provider. Through the work conducted by the ASP, many
staff members established a better understanding of the concept and are decreasing the
overuse or misuse of antibiotics. I feel I made an impact on the providers I work with, as
their clinical practice has improved in the retail clinic setting. This project has
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encouraged me to play an active role in the ASP at the retail clinic and become an
advocate in the community. I learned that I need to use my professional leadership skills
to work with providers and practice managers to conduct the DNP project. I discussed the
ASP with providers to gain a better understanding and went to the practice managers with
what was discussed. I was able to build the ASP team with providers whom I needed for
the project. Another strategy I used was buying the staff donuts and coffee, which
provided positive reinforcement as the staff became supportive and friendly. In
conclusion, I feel that I am skilled, prepared, and willing to implement further projects in
nursing practice and I am motivated to continue conducting research and improving
practice.
Completion of the Project
The completion of the ASP project had some challenges. One challenge was that
the retail clinic DNP project approval committee took a long time to approve my project.
The DNP project committee meets once a month, and projects are reviewed on a firstcome-first-served basis. It took the committee members about three months to approve
my project, which was also during the initial COVID-19 outbreak. One way I overcame
this challenge was to approach one of the committee members who acknowledged she
had time to communicate and discuss what was needed for the project. Her response to
this approach was positive and supportive. The clinical educator showed little interest in
the project and was not cooperative in establishing a working relationship. Her
availability was limited, and her interest was diminishing. One strategy that I used to
overcome this obstacle was to approach her with an appointment when she had time to
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speak and discuss what was required for the project. Her reaction to this approach was
friendly and welcoming. I learned that at times, even patience, diligence, and using all the
clinical skills may not be sufficient, and leadership may need to support and get involved.
Summary
Implementing this DNP project has offered me the opportunity to learn, practice,
evolve, and become more proficient in the competencies of the DNP project. This has
been a unique experience and has been challenging. It gave me an opportunity for growth
and development to contribute to the profession, and to implement research in nursing
practice after graduation.
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Appendix A: Antibiotic Stewardship Program (ASP) Guidelines
I. Does the Use of Wait-and-See or Delayed Antibiotic Prescriptions by ASP
Improve Antibiotic Use and Patient Outcome?
Recommendations
The guideline recommends the use of wait-and-see or delayed antibiotic prescription, in
which a prescription is given for the patient only to take it if condition worsens or does
not improve few days after the clinician visit.
II. Is Education a Useful ASP Intervention for Decreasing Inappropriate Antibiotic
Use?
Recommendations
The guideline suggests offering education sessions using lectures, or posters on teaching
providers and clients the beneficial aspect of ASP intervention for reducing inappropriate
antibiotic use.
III. Should Retail Clinic Develop and Implement ASP Guidelines Based on
Epidemiology to Standardize Prescription Practices?
Recommendations
The guideline recommends that the retail clinic use ASP guidelines and algorithms based
on epidemiology to standardize prescription practices for common infections to improve
antibiotic use and patient outcomes.
IV. Do Strategies to Enhance Prescriber-Led Routine Review of Appropriateness of
Antibiotic Regimen, Improve Antibiotic Prescribing?
Recommendations
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The guideline recommends strategies including the use of published data on prescriberled, routine review of antibiotic regimen to enhance antibiotic prescribing, and wait and
see prescribing.
VII. Should ASPS Advocate for Retail Clinic to Use Alternative Dosing Strategies
Based on Pharmacodynamic Principles to Enhance Outcome, Decrease Cost and
Side Effects for aminoglycosides?
Recommendations
The guideline suggests the retail clinic to utilize pharmacokinetic monitoring and dose
adjustment for aminoglycosides antibiotics to reduce side effects, reduce cost, and
improve outcome.
VIII. Should ASPs Incorporate Interventions to Increase Oral Antibiotics Use as a
Strategy to Enhance or Decrease Cost?
Recommendations
The guideline recommends the use of oral antibiotics to decrease the cost.
IX. Should the ASPs Implement Interventions to Decrease Antibiotic Therapy to the
Shortest Duration?
Recommendations
The guideline suggests the use of the shorter duration of therapy or specifying the
duration of therapy at the time of antibiotic ordering.
X. Should ASPs Work with the Microbiology Laboratory to Reporting of ASP
Culture and Sensitivity Test Results?
Recommendations
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The guideline recommends the use of microbiology laboratory or susceptible culture test
results in prescribing antibiotics in common clinical conditions.
XI. Should ASPs Advocate for Use of Rapid Viral Testing to Reduce the Use of
Unwarranted Antibiotics?
Recommendations
The guideline suggests rapid viral testing. If the test results are viral, supportive therapy
follows, or if the test results reveal a bacterial infection, 24 hours wait-and-see antibiotic
prescription is suggested.
XII. What is the Best Measure of Cost on Antibiotics to Assess the Impact of ASPs
and its Intervention?
Recommendations
The guideline recommends measuring antibiotic costs depending on prescriptions or
administrations, rather than on purchasing data.
XIII. Should ASPs Advocate for Use of Rapid Diagnostic Testing Together with
Culture and Sensitivity Testing for Antibiotic Prescribing?
Recommendations
The guideline suggests the use of rapid diagnostic testing together with culture and
sensitivity testing for antibiotic prescribing.
XIV. Should Computerized Clinical Decision Support Incorporated at the Time of
Prescribing into ASPs?
Recommendations
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The guideline suggests the implementation of a computerized surveillance system that
synthesizes data derived from the electronic medical records and other data sources that
can improve the work of ASP by recognizing an opportunity for intervention.
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Appendix B: Approach and Implication to Rating Quality of Evidence and Strength of
Recommendation Using the Grading Recommendations Assessment, Development and
Evaluation (GRADE) Methodology
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Appendix C: Chart Tool
New Antibiotic Start
Effective Feb 21, 2021
Instructions: Please complete the following assess the ASP. The tool is completed weekly
on all
patients who received antibiotics by NP. The completed tool is forwarded to physician for
quality assessment.
Week of______________________________(Week of: that is Monday to Sunday Jan
Feb March April May June July Aug Sep Oct Nov Dec
Patient
Name
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.

Date
Antibiotic
Started

Diagnosis
for
Antibiotic

Duration of
Antibiotic

Results of
lab

Pathogen
growing
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Appendix D: Chart Tool Monthly Results
New Antibiotic Start Monthly Results
Data Collected
by_______________________________________________________________
First Name.
Last Name.
Title.
Date
Monthly Totals ______________________________ Jan Feb March April May June
July Aug Sep Oct Nov Dec
Threshold for compliance: %
Number of New
Antibiotics
Ordered

For Example: 8

Number of
patients and
duration of
number of
days
Antibiotics
ordered
6/8

Number of
patients with
diagnosis to
support
Antibiotics
orders
6/8

Number of
patients with
culture
ordered to
confirm
diagnosis for
Antibiotics
5/8

Number of
culture results
received prior
to ordering
Antibiotics

4/8

Monthly Results:
% compliance
For Example:
Monthly %

88.5%

88.5%

74%

63.5%

